Strategic collaboration Target Humboldt Fund's interest in early-stage biotech ventures by presenting co-investment opportunities, especially in synthetic biology and life sciences startups that align with their thesis of transforming chemicals, materials, foods, and medicines.

Portfolio expansion Highlight potential add-on investments or follow-on rounds for Cellino Biotech and similar portfolio companies, offering strategic partnerships, manufacturing scale, or distribution partnerships to accelerate global market adoption.

Impact-driven fund Emphasize opportunities that demonstrate measurable societal impact and sustainability, aligning with their mission to solve world-critical issues via emerging biotech, which can resonate with impact-focused co-investors and LPs.

Tech-enabled outreach Leverage their tech stack and online presence by providing content, webinars, or success stories that showcase biotech breakthroughs, investor updates, and value proposition to attract their attention and engagement.

Strategic partnerships Propose collaboration avenues beyond funding, such as research collaborations, pilot programs, or access to Bayer Leaps by Bayer and other big-name co-investors to strengthen credibility and de-risk early-stage opportunities.